Roche · 1 day ago
2026 Summer Intern - Product Development Data Sciences and Analytics
Roche is a leading biotechnology company, and they are seeking a 2026 Summer Intern in Product Development Data Sciences and Analytics. This internship will focus on statistical methodology to enhance decision-making in drug development, involving collaboration with data scientists and conducting research to support Phase 3 studies.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Perform literature search
Connect with full-time employees who are subject matter experts who are active in this area
Conduct research (e.g., simulations, derivations)
Summarize and communicate findings to internal stakeholders
Enable adoption/implementation through documentation, publication, and/or software
Qualification
Required
Must be pursuing a PhD (enrolled student)
Biostatistics, Statistics, Mathematics or other related fields
Understanding of statistical methods
Experience in Working knowledge of programming in R and version control systems like Git
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Recent News
2026-01-22
2026-01-22
Company data provided by crunchbase